Sandra Anderson

Market Access

A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.